Free Trial
→ Warning: “DOGE Collapse” imminent (From Altimetry) (Ad) Buy HSTM Stock  Free HSTM Stock Alerts

HealthStream (HSTM) Financials

HealthStream logo
$33.84 -0.23 (-0.66%)
As of 10:44 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for HealthStream

Annual Income Statements for HealthStream

This table shows HealthStream's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 10 8.62 3.76 10 32 16 14 5.85 12 15 20
Consolidated Net Income / (Loss)		 10 8.62 3.76 10 32 16 14 5.85 12 15 20
Net Income / (Loss) Continuing Operations		 10 8.62 4.79 8.84 13 14 14 5.85 12 15 20
Total Pre-Tax Income 		17 14 7.75 10 17 18 18 7.77 16 19 25
Total Operating Income		 16 14 7.17 9.41 15 15 16 8.06 12 16 21
Total Gross Profit		 97 120 117 128 136 150 155 166 176 184 194
Total Revenue		 171 209 192 215 232 254 245 257 267 279 292
Operating Revenue		 171 209 192 215 232 254 245 257 267 279 292
Total Cost of Revenue		 74 89 75 87 96 104 89 91 91 95 98
Operating Cost of Revenue		 74 89 75 87 96 104 89 91 91 95 98
Total Operating Expenses		 80 106 110 118 120 136 140 158 163 168 172
Selling, General & Admin Expense		 23 29 30 31 34 41 42 40 37 36 35
Marketing Expense		 30 36 35 39 36 38 35 39 44 46 47
Research & Development Expense		 16 24 24 24 26 29 32 42 44 46 49
Depreciation Expense		 11 17 20 24 24 28 30 37 38 41 41
Total Other Income / (Expense), net		 0.15 0.16 0.58 0.73 1.08 3.21 2.01 -0.29 3.14 2.49 3.52
Interest & Investment Income		 - - - - - - - - 0.44 2.36 3.83
Other Income / (Expense), net		 0.15 0.16 0.58 0.73 1.08 3.21 2.01 -0.29 2.69 0.14 -0.32
Income Tax Expense		 6.13 5.10 2.96 1.30 3.32 3.73 3.73 1.92 3.49 3.30 4.80
Basic Earnings per Share		 $0.38 $0.29 $0.12 $0.31 $1.00 $0.49 $0.44 $0.19 $0.39 $0.50 $0.66
Weighted Average Basic Shares Outstanding		 27.57M 30.06M 31.72M 31.86M 32.26M 32.37M 31.96M 31.53M 30.65M 30.57M 30.39M
Diluted Earnings per Share		 $0.37 $0.28 $0.12 $0.31 $1.00 $0.49 $0.44 $0.18 $0.39 $0.50 $0.66
Weighted Average Diluted Shares Outstanding		 28.02M 30.44M 32.07M 32.20M 32.34M 32.43M 31.99M 31.62M 30.72M 30.67M 30.54M
Weighted Average Basic & Diluted Shares Outstanding		 27.40M 29.70M 31.30M 32.30M 32.20M 32.38M 31.49M 30.94M 30.58M 30.30M 30.43M
Cash Dividends to Common per Share		 - - - - $1.00 - - $0.00 $0.00 $0.10 $0.11

Quarterly Income Statements for HealthStream

This table shows HealthStream's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 3.67 2.45 2.62 4.13 3.87 4.59 5.23 4.17 5.73 4.89
Consolidated Net Income / (Loss)		 3.67 2.45 2.62 4.13 3.87 4.59 5.23 4.17 5.73 4.89
Net Income / (Loss) Continuing Operations		 3.67 2.45 2.62 4.13 3.87 4.59 5.23 4.17 5.73 4.89
Total Pre-Tax Income 		4.93 3.27 3.14 4.50 5.45 5.42 6.54 5.30 7.48 5.48
Total Operating Income		 2.38 3.08 2.89 4.01 4.86 4.26 5.69 4.41 6.50 4.69
Total Gross Profit		 44 45 45 46 47 47 48 48 49 49
Total Revenue		 67 69 69 69 70 71 73 72 73 74
Operating Revenue		 67 69 69 69 70 71 73 72 73 74
Total Cost of Revenue		 23 24 24 24 24 24 25 24 24 25
Operating Cost of Revenue		 23 24 24 24 24 24 25 24 24 25
Total Operating Expenses		 42 42 42 42 42 42 42 43 42 44
Selling, General & Admin Expense		 9.10 9.01 8.87 9.06 9.30 8.44 8.31 9.56 8.46 8.81
Marketing Expense		 11 11 12 11 11 11 12 11 11 12
Research & Development Expense		 11 12 12 11 11 12 12 12 12 13
Depreciation Expense		 9.59 9.61 9.93 10 10 11 10 10 10 10
Total Other Income / (Expense), net		 2.54 0.19 0.25 0.49 0.59 1.16 0.85 0.89 0.98 0.79
Other Income / (Expense), net		 2.54 -0.25 0.25 0.49 0.59 -1.20 0.85 0.89 0.98 -3.04
Income Tax Expense		 1.26 0.82 0.52 0.37 1.59 0.83 1.32 1.13 1.75 0.59
Basic Earnings per Share		 $0.12 $0.08 $0.09 $0.13 $0.13 $0.15 $0.17 $0.14 $0.19 $0.16
Weighted Average Basic Shares Outstanding		 30.57M 30.65M 30.59M 30.68M 30.68M 30.57M 30.31M 30.40M 30.41M 30.39M
Diluted Earnings per Share		 $0.12 $0.08 $0.09 $0.13 $0.13 $0.15 $0.17 $0.14 $0.19 $0.16
Weighted Average Diluted Shares Outstanding		 30.66M 30.72M 30.66M 30.78M 30.77M 30.67M 30.42M 30.53M 30.59M 30.54M
Weighted Average Basic & Diluted Shares Outstanding		 30.57M 30.58M 30.68M 30.69M 30.29M 30.30M 30.40M 30.41M 30.41M 30.43M
Cash Dividends to Common per Share		 $0.00 - $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03

Annual Cash Flow Statements for HealthStream

This table details how cash moves in and out of HealthStream's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 22 0.02 -32 35 50 -2.78 -95 10 -0.88 -5.69 19
Net Cash From Operating Activities		 34 35 24 47 43 66 36 42 51 64 58
Net Cash From Continuing Operating Activities		 34 35 24 43 44 66 36 42 51 64 58
Net Income / (Loss) Continuing Operations		 10 8.62 4.79 8.84 13 14 14 5.85 12 15 20
Consolidated Net Income / (Loss)		 10 8.62 3.76 10 32 16 14 5.85 12 15 20
Depreciation Expense		 11 17 20 24 24 28 30 37 38 41 41
Amortization Expense		 - - - - 7.66 8.31 8.77 9.17 11 11 12
Non-Cash Adjustments To Reconcile Net Income		 0.09 2.00 3.17 3.72 4.03 4.32 -1.73 5.40 1.07 4.24 5.66
Changes in Operating Assets and Liabilities, net		 13 7.30 -4.44 6.00 -4.92 11 -15 -15 -11 -8.06 -22
Net Cash From Investing Activities		 -16 -135 -57 -12 37 -68 -110 -26 -28 -57 -34
Net Cash From Continuing Investing Activities		 -16 -135 -56 -8.82 37 -68 -110 -26 -28 -57 -34
Purchase of Property, Plant & Equipment		 -10 -15 -14 -15 -18 -37 -19 -25 -25 -28 -28
Acquisitions		 -13 -89 -55 -0.50 0.00 -27 -121 -4.71 -3.97 -6.62 -1.30
Purchase of Investments		 -45 -85 -107 -83 -58 -91 -62 -6.97 -13 -50 -74
Sale of Property, Plant & Equipment		 - - 0.98 - 0.00 0.02 0.00 0.00 0.03 0.00 0.00
Sale and/or Maturity of Investments		 53 55 119 90 69 81 92 11 14 28 70
Net Cash From Financing Activities		 3.74 100 0.05 0.00 -30 -0.92 -20 -6.21 -24 -13 -4.52
Net Cash From Continuing Financing Activities		 3.74 100 0.05 0.00 -30 -0.92 -20 -6.21 -24 -13 -4.52
Repayment of Debt		 - -28 - - -0.10 - - 0.00 0.00 -0.12 0.00
Repurchase of Common Equity		 - - - - 0.00 0.00 -20 -5.01 -23 -8.93 0.00
Payment of Dividends		 -0.42 -0.63 - - -32 -0.10 -0.04 -0.02 0.00 -3.06 -3.40
Other Financing Activities, net		 4.17 2.58 0.05 0.00 2.24 -0.82 -0.44 -1.18 -0.57 -0.93 -1.11
Effect of Exchange Rate Changes		 - - - - - - 0.06 -0.11 0.02 -0.02 -0.04
Cash Interest Paid		 0.06 0.19 0.08 0.10 0.12 0.10 0.10 0.13 0.10 0.13 0.10
Cash Income Taxes Paid		 1.64 2.65 2.50 0.64 17 0.63 0.88 -0.09 0.72 2.61 8.70

Quarterly Cash Flow Statements for HealthStream

This table details how cash moves in and out of HealthStream's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 11 -2.23 2.81 -23 18 -3.79 12 -6.28 11 1.98
Net Cash From Operating Activities		 15 8.11 21 4.95 25 14 21 6.45 19 11
Net Cash From Continuing Operating Activities		 15 8.11 21 4.95 25 14 21 6.45 19 11
Net Income / (Loss) Continuing Operations		 3.67 2.45 2.62 4.13 3.87 4.59 5.23 4.17 5.72 4.89
Consolidated Net Income / (Loss)		 3.67 2.45 2.62 4.13 3.87 4.59 5.23 4.17 5.72 4.89
Depreciation Expense		 9.59 9.61 9.93 10 10 11 10 10 10 10
Amortization Expense		 2.80 2.77 2.71 2.75 3.00 3.03 2.96 3.00 3.10 3.42
Non-Cash Adjustments To Reconcile Net Income		 -1.67 1.03 1.20 1.11 1.13 0.81 0.92 2.37 0.97 1.40
Changes in Operating Assets and Liabilities, net		 0.71 -7.75 4.08 -13 6.27 -5.14 1.50 -13 -0.76 -9.01
Net Cash From Investing Activities		 -4.05 -10 -17 -26 -3.92 -9.38 -7.12 -12 -6.87 -8.07
Net Cash From Continuing Investing Activities		 -4.05 -10 -17 -26 -3.92 -9.38 -7.12 -12 -6.87 -8.07
Purchase of Property, Plant & Equipment		 -5.96 -6.14 -8.45 -6.25 -6.72 -6.60 -7.76 -6.71 -6.84 -6.84
Acquisitions		 - 0.04 -6.62 - - - 0.00 - - -1.30
Purchase of Investments		 -3.58 -7.87 -2.85 -29 -6.25 -12 -14 -20 -17 -23
Sale and/or Maturity of Investments		 5.49 3.60 1.00 9.00 9.05 9.25 15 15 17 23
Net Cash From Financing Activities		 -0.02 -0.05 -0.79 -1.54 -2.44 -8.27 -1.70 -0.86 -0.92 -1.03
Net Cash From Continuing Financing Activities		 -0.02 -0.05 -0.79 -1.54 -2.44 -8.27 -1.70 -0.86 -0.92 -1.03
Payment of Dividends		 - - 0.00 -1.53 -0.77 -0.76 -0.85 -0.85 -0.85 -0.85
Other Financing Activities, net		 -0.02 -0.05 -0.79 -0.01 -0.02 -0.12 -0.86 -0.01 -0.07 -0.18
Effect of Exchange Rate Changes		 0.01 0.07 -0.02 -0.06 0.01 0.05 -0.04 0.04 0.04 -0.08

Annual Balance Sheets for HealthStream

This table presents HealthStream's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 257 380 396 411 442 500 487 498 500 511
Total Current Assets		 175 210 177 200 241 115 107 114 130 153
Cash & Equivalents		 82 82 50 85 134 37 47 46 40 59
Short-Term Investments		 39 67 54 46 34 9.93 5.04 7.89 31 38
Accounts Receivable		 33 36 47 38 41 46 35 43 38 35
Prepaid Expenses		 13 14 18 16 14 9.57 9.16 15 18 18
Other Current Assets		 5.77 8.17 8.69 8.33 18 13 11 2.65 3.03 2.47
Plant, Property, & Equipment, net		 9.44 12 10 8.09 16 22 18 15 13 11
Total Noncurrent Assets		 73 158 208 203 185 363 362 368 357 347
Goodwill		 42 83 110 86 86 178 183 192 191 191
Intangible Assets		 28 70 95 85 78 127 122 119 109 99
Other Noncurrent Operating Assets		 2.04 0.93 0.60 0.75 17 50 50 52 57 57
Total Liabilities & Shareholders' Equity		 257 380 396 411 442 500 487 498 500 511
Total Liabilities		 89 99 110 111 123 166 148 164 159 151
Total Current Liabilities		 77 89 95 101 107 119 100 117 118 116
Accounts Payable		 4.75 4.62 3.13 4.18 8.50 9.33 5.13 7.29 7.47 6.63
Accrued Expenses		 16 16 21 22 32 29 21 30 18 15
Current Deferred Revenue		 54 65 69 65 66 81 74 79 84 84
Current Employee Benefit Liabilities		 2.31 3.31 1.99 2.76 - - - - 9.49 9.51
Total Noncurrent Liabilities		 12 10 15 9.88 16 47 47 46 41 36
Noncurrent Deferred Revenue		 3.66 4.35 7.86 6.29 2.87 1.60 1.58 2.94 2.17 1.66
Noncurrent Deferred & Payable Income Tax Liabilities		 5.84 4.76 5.97 - 11 15 18 18 16 15
Other Noncurrent Operating Liabilities		 2.65 1.06 1.10 1.05 2.21 31 28 26 23 19
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 168 280 286 300 319 334 339 334 341 359
Total Preferred & Common Equity		 168 280 286 300 319 334 339 334 341 359
Preferred Stock		 - - - - - - - - 0.00 0.00
Total Common Equity		 168 280 286 300 319 334 339 334 341 359
Common Stock		 175 279 281 283 287 272 271 255 249 252
Retained Earnings		 -7.03 1.59 5.35 18 32 62 68 80 92 109
Accumulated Other Comprehensive Income / (Loss)		 -0.04 -0.07 -0.05 -0.04 -0.02 0.00 0.11 -0.98 -0.69 -2.05

Quarterly Balance Sheets for HealthStream

This table presents HealthStream's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 481 503 493 498 512 500 503
Total Current Assets		 104 125 118 127 147 139 146
Cash & Equivalents		 48 49 26 44 52 46 57
Short-Term Investments		 3.59 9.82 30 28 31 37 37
Accounts Receivable		 33 47 41 35 44 36 32
Prepaid Expenses		 9.26 11 9.88 11 18 17 16
Other Current Assets		 11 8.21 11 9.51 2.09 3.12 3.16
Plant, Property, & Equipment, net		 16 15 14 14 13 12 11
Total Noncurrent Assets		 361 363 361 358 352 349 346
Long-Term Investments		 4.64 4.39 4.28 4.19 4.10 4.05 3.98
Goodwill		 188 191 191 191 191 191 191
Intangible Assets		 117 118 114 111 106 103 100
Other Noncurrent Operating Assets		 51 50 51 51 51 51 51
Total Liabilities & Shareholders' Equity		 481 503 493 498 512 500 503
Total Liabilities		 151 167 153 156 167 150 147
Total Current Liabilities		 105 121 109 115 126 112 111
Accounts Payable		 22 20 22 3.52 5.31 5.81 4.44
Accrued Expenses		 5.61 6.53 5.24 28 22 19 23
Current Deferred Revenue		 78 94 82 83 98 87 83
Total Noncurrent Liabilities		 46 46 44 41 41 38 37
Capital Lease Obligations		 - - - - 19 19 18
Noncurrent Deferred Revenue		 1.26 2.56 2.26 2.74 2.08 1.89 1.67
Noncurrent Deferred & Payable Income Tax Liabilities		 19 19 17 15 17 16 15
Other Noncurrent Operating Liabilities		 26 25 24 23 2.25 2.22 1.99
Total Equity & Noncontrolling Interests		 330 336 341 342 345 349 355
Total Preferred & Common Equity		 330 336 341 342 345 349 355
Total Common Equity		 330 336 341 342 345 349 355
Common Stock		 254 255 256 255 249 250 251
Retained Earnings		 78 82 85 89 97 100 105
Accumulated Other Comprehensive Income / (Loss)		 -1.42 -1.02 -0.89 -1.24 -1.17 -1.22 -0.88

Annual Metrics and Ratios for HealthStream

This table displays calculated financial ratios and metrics derived from HealthStream's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 29.04% 22.45% -8.08% 11.85% 7.78% 9.71% -3.65% 4.85% 3.94% 4.59% 4.51%
EBITDA Growth		 20.97% 11.89% -8.46% 21.58% 41.76% 11.63% 4.95% -5.34% 18.49% 7.92% 8.68%
EBIT Growth		 11.31% -16.96% -43.49% 30.81% 63.46% 8.17% -0.59% -56.43% 94.97% 6.70% 29.80%
NOPAT Growth		 23.85% -17.31% -47.98% 85.00% 51.05% -5.89% 7.30% -51.52% 59.31% 36.31% 30.43%
Net Income Growth		 23.47% -17.06% -56.44% 166.42% 222.04% -51.05% -10.65% -58.52% 106.86% 25.82% 31.51%
EPS Growth		 23.33% -24.32% -57.14% 158.33% 222.58% -51.00% -10.20% -59.09% 116.67% 28.21% 32.00%
Operating Cash Flow Growth		 26.62% 1.93% -30.60% 92.75% -7.42% 51.82% -45.36% 18.15% 20.77% 24.97% -9.86%
Free Cash Flow Firm Growth		 -8.50% -1,353.20% 35.80% 199.84% -87.29% -50.03% -3,841.91% 105.99% 107.98% 36.54% 28.50%
Invested Capital Growth		 10.79% 182.92% 40.69% -21.85% 4.52% 5.89% 80.65% -0.25% -1.57% -2.18% -2.77%
Revenue Q/Q Growth		 5.10% 5.30% -13.89% 16.47% 2.01% 1.14% -0.36% 0.99% 1.60% 0.74% 1.27%
EBITDA Q/Q Growth		 6.37% -1.13% -4.44% 7.37% 24.50% 2.88% -3.01% -0.73% 6.83% 1.42% -4.40%
EBIT Q/Q Growth		 4.37% -13.86% -9.86% 5.88% 13.08% 1.92% -13.92% -17.39% 28.13% -1.27% -15.24%
NOPAT Q/Q Growth		 9.55% -9.77% -18.61% 36.77% -4.89% 6.10% -14.06% -17.47% 38.42% 11.04% 3.34%
Net Income Q/Q Growth		 9.33% -8.82% -36.12% 74.16% -3.47% 6.00% -16.38% -18.31% 30.64% 16.38% 1.51%
EPS Q/Q Growth		 12.12% -15.15% -33.33% 72.22% -2.91% 8.89% -18.52% -21.74% 34.48% 16.28% 1.54%
Operating Cash Flow Q/Q Growth		 5.34% 12.27% -0.60% 4.00% 8.52% -1.99% -18.21% 1.99% 4.40% 9.79% -4.40%
Free Cash Flow Firm Q/Q Growth		 87.88% 2.61% -1.57% 136.75% -86.12% 155.44% -954.31% 107.83% 116.51% -1.14% 196.57%
Invested Capital Q/Q Growth		 0.70% -1.99% -1.58% -16.67% 6.32% 0.61% 56.22% 2.46% 0.67% 1.27% -4.52%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 56.56% 57.23% 60.98% 59.42% 58.55% 59.12% 63.51% 64.54% 65.84% 65.95% 66.42%
EBITDA Margin		 16.08% 14.70% 14.64% 15.91% 20.92% 21.29% 23.19% 20.94% 23.87% 24.63% 25.61%
Operating Margin		 9.59% 6.49% 3.73% 4.38% 6.69% 5.79% 6.46% 3.14% 4.67% 5.74% 7.30%
EBIT Margin		 9.68% 6.56% 4.03% 4.72% 7.16% 7.06% 7.28% 3.03% 5.67% 5.79% 7.19%
Profit (Net Income) Margin		 6.09% 4.12% 1.95% 4.66% 13.91% 6.21% 5.76% 2.28% 4.53% 5.45% 6.86%
Tax Burden Percent		 62.91% 62.84% 48.44% 98.66% 194.37% 87.96% 79.06% 75.26% 77.58% 82.18% 80.66%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 102.93% 114.58% 118.28%
Effective Tax Rate		 37.09% 37.16% 38.20% 12.84% 20.05% 20.82% 20.94% 24.74% 22.42% 17.82% 19.34%
Return on Invested Capital (ROIC)		 23.99% 9.86% 2.88% 5.12% 8.63% 7.71% 5.74% 2.16% 3.48% 4.83% 6.46%
ROIC Less NNEP Spread (ROIC-NNEP)		 23.91% 9.78% 3.41% 3.77% -3.32% -41.27% 8.84% 2.55% -0.67% 1.67% 3.09%
Return on Net Nonoperating Assets (RNNOA)		 -17.44% -6.01% -1.56% -1.71% 1.78% 2.17% 2.70% -0.43% 0.12% -0.32% -0.74%
Return on Equity (ROE)		 6.55% 3.85% 1.33% 3.41% 10.41% 9.89% 8.44% 1.74% 3.59% 4.51% 5.72%
Cash Return on Invested Capital (CROIC)		 13.76% -85.68% -30.93% 29.65% 4.20% 2.00% -51.74% 2.41% 5.06% 7.04% 9.27%
Operating Return on Assets (OROA)		 7.03% 4.31% 2.00% 2.51% 3.89% 3.85% 3.60% 1.57% 3.08% 3.24% 4.15%
Return on Assets (ROA)		 4.42% 2.71% 0.97% 2.48% 7.55% 3.39% 2.85% 1.18% 2.46% 3.05% 3.96%
Return on Common Equity (ROCE)		 6.55% 3.85% 1.33% 3.41% 10.41% 9.89% 8.44% 1.74% 3.59% 4.51% 5.72%
Return on Equity Simple (ROE_SIMPLE)		 6.19% 3.08% 1.31% 3.33% 10.10% 0.00% 4.22% 1.72% 3.62% 4.46% 5.57%
Net Operating Profit after Tax (NOPAT)		 10 8.52 4.43 8.20 12 12 13 6.06 9.66 13 17
NOPAT Margin		 6.04% 4.08% 2.31% 3.82% 5.35% 4.59% 5.11% 2.36% 3.62% 4.72% 5.89%
Net Nonoperating Expense Percent (NNEP)		 0.08% 0.07% -0.52% 1.36% 11.95% 48.98% -3.11% -0.39% 4.14% 3.16% 3.37%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 2.89% 3.86% 4.78%
Cost of Revenue to Revenue		 43.44% 42.77% 39.02% 40.58% 41.45% 40.88% 36.49% 35.46% 34.16% 34.05% 33.58%
SG&A Expenses to Revenue		 13.42% 14.00% 15.85% 14.65% 14.87% 15.97% 17.11% 15.46% 13.82% 12.78% 12.05%
R&D to Revenue		 9.65% 11.59% 12.61% 11.24% 11.11% 11.46% 13.20% 16.23% 16.59% 16.32% 16.76%
Operating Expenses to Revenue		 46.97% 50.75% 57.25% 55.04% 51.86% 53.32% 57.05% 61.40% 61.18% 60.21% 59.12%
Earnings before Interest and Taxes (EBIT)		 17 14 7.75 10 17 18 18 7.77 15 16 21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 27 31 28 34 48 54 57 54 64 69 75
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.62 2.37 2.65 2.34 2.43 2.59 2.06 2.44 2.26 2.39 2.69
Price to Tangible Book Value (P/TBV)		 7.88 5.21 9.27 5.43 5.00 5.66 24.29 23.67 32.76 20.03 13.97
Price to Revenue (P/Rev)		 4.55 3.17 3.94 3.27 3.35 3.44 2.81 3.22 2.82 2.92 3.32
Price to Earnings (P/E)		 74.65 76.91 201.66 70.33 24.06 55.45 48.75 141.33 62.31 53.60 48.34
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 4.17% 0.00% 0.00% 0.00% 0.00% 0.37% 0.43%
Earnings Yield		 1.34% 1.30% 0.50% 1.42% 4.16% 1.80% 2.05% 0.71% 1.61% 1.87% 2.07%
Enterprise Value to Invested Capital (EV/IC)		 14.47 4.00 3.62 4.05 4.11 4.47 2.26 2.74 2.52 2.76 3.32
Enterprise Value to Revenue (EV/Rev)		 3.83 2.44 3.39 2.65 2.60 2.73 2.59 2.99 2.60 2.67 2.98
Enterprise Value to EBITDA (EV/EBITDA)		 23.79 16.62 23.15 16.63 12.44 12.84 11.16 14.27 10.91 10.83 11.65
Enterprise Value to EBIT (EV/EBIT)		 39.54 37.21 83.95 56.08 36.38 38.75 35.55 98.78 45.90 46.07 41.49
Enterprise Value to NOPAT (EV/NOPAT)		 63.40 59.92 146.84 69.36 48.69 59.61 50.67 126.53 71.95 56.53 50.67
Enterprise Value to Operating Cash Flow (EV/OCF)		 19.07 14.62 26.85 12.17 13.94 10.58 17.66 18.10 13.58 11.63 15.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 110.55 0.00 0.00 11.98 99.93 230.44 0.00 113.55 49.46 38.79 35.29
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.73 -0.61 -0.46 -0.45 -0.54 -0.05 0.31 -0.17 -0.17 -0.19 -0.24
Leverage Ratio		 1.48 1.42 1.37 1.38 1.38 2.92 2.96 1.47 1.46 1.48 1.44
Compound Leverage Factor		 1.48 1.42 1.37 1.38 1.38 2.92 2.96 1.47 1.51 1.69 1.71
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 6.50 5.07 4.95 4.76 4.90 0.00 3.25 4.15 3.62 4.03 4.93
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.26 2.35 1.87 1.98 2.26 2.14 0.96 1.06 0.98 1.10 1.32
Quick Ratio		 2.02 2.10 1.59 1.67 1.96 1.93 0.78 0.87 0.82 0.93 1.15
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 5.91 -74 -48 47 6.03 3.02 -113 6.76 14 19 25
Operating Cash Flow to CapEx		 335.78% 227.34% 189.18% 309.11% 234.40% 179.91% 190.79% 167.23% 204.13% 228.42% 204.89%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.73 0.66 0.50 0.53 0.54 0.55 0.49 0.52 0.54 0.56 0.58
Accounts Receivable Turnover		 5.84 6.01 4.59 5.03 5.86 7.12 6.40 6.34 6.87 6.88 7.91
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 18.47 19.08 16.92 23.44 19.34 0.00 0.00 12.78 15.96 19.59 24.56
Accounts Payable Turnover		 20.99 19.08 19.36 23.88 15.15 0.00 0.00 12.59 14.69 12.88 13.90
Days Sales Outstanding (DSO)		 62.53 60.70 79.54 72.53 62.26 51.26 57.01 57.60 53.10 53.07 46.16
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 17.39 19.13 18.85 15.29 24.09 0.00 0.00 28.99 24.86 28.33 26.26
Cash Conversion Cycle (CCC)		 45.14 41.57 60.69 57.24 38.17 51.26 57.01 28.61 28.24 24.74 19.90
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 45 128 180 140 147 155 281 280 276 270 262
Invested Capital Turnover		 3.98 2.42 1.25 1.34 1.61 1.68 1.12 0.92 0.96 1.02 1.10
Increase / (Decrease) in Invested Capital		 4.39 83 52 -39 6.35 8.64 125 -0.69 -4.39 -6.02 -7.48
Enterprise Value (EV)		 653 510 651 569 603 695 634 767 695 744 870
Market Capitalization		 776 663 757 704 775 874 687 826 753 815 967
Book Value per Share		 $6.07 $8.86 $9.01 $9.41 $9.87 $0.00 $10.55 $10.74 $10.93 $11.25 $11.82
Tangible Book Value per Share		 $3.56 $4.02 $2.57 $4.06 $4.80 $0.00 $0.89 $1.11 $0.75 $1.34 $2.28
Total Capital		 168 280 286 300 319 0.00 334 339 334 341 359
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -123 -153 -106 -135 -172 -180 -53 -59 -58 -71 -97
Capital Expenditures (CapEx)		 10 15 13 15 18 36 19 25 25 28 28
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -24 -29 -21 -32 -34 -53 -51 -45 -57 -59 -60
Debt-free Net Working Capital (DFNWC)		 97 120 82 99 135 119 -4.72 6.50 -2.84 12 37
Net Working Capital (NWC)		 97 120 82 99 135 119 -4.72 6.50 -2.84 12 37
Net Nonoperating Expense (NNE)		 -0.09 -0.10 0.68 -1.80 -20 -4.11 -1.59 0.22 -2.43 -2.05 -2.84
Net Nonoperating Obligations (NNO)		 -123 -153 -106 -160 -172 155 -53 -59 -58 -71 -97
Total Depreciation and Amortization (D&A)		 11 17 20 24 32 36 39 46 49 53 54
Debt-free, Cash-free Net Working Capital to Revenue		 -13.84% -13.65% -10.78% -15.10% -14.78% -21.05% -20.92% -17.71% -21.27% -21.24% -20.50%
Debt-free Net Working Capital to Revenue		 57.03% 57.64% 42.92% 45.91% 58.10% 46.98% -1.93% 2.53% -1.06% 4.25% 12.83%
Net Working Capital to Revenue		 57.03% 57.64% 42.92% 45.91% 58.10% 46.98% -1.93% 2.53% -1.06% 4.25% 12.83%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.38 $0.29 $0.12 $0.31 $1.00 $0.49 $0.44 $0.19 $0.39 $0.50 $0.66
Adjusted Weighted Average Basic Shares Outstanding		 27.57M 30.06M 31.72M 31.86M 32.26M 32.37M 31.96M 31.53M 30.65M 30.57M 30.39M
Adjusted Diluted Earnings per Share		 $0.37 $0.28 $0.12 $0.31 $1.00 $0.49 $0.44 $0.18 $0.39 $0.50 $0.66
Adjusted Weighted Average Diluted Shares Outstanding		 28.02M 30.44M 32.07M 32.20M 32.34M 32.43M 31.99M 31.62M 30.72M 30.67M 30.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.68M 31.65M 31.78M 32.04M 32.33M 32.38M 31.49M 30.94M 30.58M 30.30M 30.43M
Normalized Net Operating Profit after Tax (NOPAT)		 10 8.52 4.43 8.20 12 12 13 6.06 9.66 13 17
Normalized NOPAT Margin		 6.04% 4.08% 2.31% 3.82% 5.35% 4.59% 5.11% 2.36% 3.62% 4.72% 5.89%
Pre Tax Income Margin		 9.68% 6.56% 4.03% 4.72% 7.16% 7.06% 7.28% 3.03% 5.84% 6.63% 8.50%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 4.08% 7.34% 0.00% 0.00% 100.55% 0.61% 0.28% 0.33% 0.00% 20.10% 17.01%
Augmented Payout Ratio		 4.08% 7.34% 0.00% 0.00% 100.55% 0.61% 142.35% 86.01% 191.36% 78.79% 17.01%

Quarterly Metrics and Ratios for HealthStream

This table displays calculated financial ratios and metrics derived from HealthStream's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 4.98% 6.53% 5.48% 5.42% 4.54% 2.98% 5.53% 3.41% 3.92% 5.18%
EBITDA Growth		 30.99% 36.53% 1.37% 12.03% 8.92% 9.24% 25.71% 6.84% 9.53% -6.52%
EBIT Growth		 192.11% 666.13% -16.44% 23.90% 10.72% 8.35% 108.31% 17.78% 37.15% -46.19%
NOPAT Growth		 11.65% 814.80% -22.26% 46.86% 94.50% 56.38% 88.28% -5.77% 44.23% 15.88%
Net Income Growth		 144.40% 732.82% -9.33% 34.06% 5.48% 87.42% 99.28% 0.85% 48.05% 6.47%
EPS Growth		 140.00% 500.00% 0.00% 30.00% 8.33% 87.50% 88.89% 7.69% 46.15% 6.67%
Operating Cash Flow Growth		 24.66% 36.29% -0.55% -32.46% 63.38% 70.35% 1.93% 30.38% -22.53% -19.20%
Free Cash Flow Firm Growth		 101.40% 1,708.98% -102.67% 315.33% 755.87% 43.70% 739.23% -39.74% -130.28% 21.14%
Invested Capital Growth		 0.18% -1.57% 0.95% -0.41% -2.76% -2.18% 1.31% 0.20% 3.12% -2.77%
Revenue Q/Q Growth		 2.51% 1.86% 0.60% 0.37% 1.65% 0.34% 3.09% -1.65% 2.15% 1.56%
EBITDA Q/Q Growth		 11.01% -12.16% 0.81% 10.74% 7.92% -11.89% 4.56% -5.88% 10.64% -24.81%
EBIT Q/Q Growth		 35.60% -42.64% -3.92% 43.27% 21.18% -43.87% 20.79% -19.00% 41.11% -77.98%
NOPAT Q/Q Growth		 -29.26% 30.09% 4.66% 52.48% -6.32% 4.60% 26.02% -23.69% 43.39% -15.97%
Net Income Q/Q Growth		 18.91% -33.20% 7.10% 57.57% -6.44% 18.70% 13.88% -20.26% 37.36% -14.64%
EPS Q/Q Growth		 20.00% -33.33% 12.50% 44.44% 0.00% 15.38% 13.33% -17.65% 35.71% -15.79%
Operating Cash Flow Q/Q Growth		 106.10% -46.30% 153.34% -75.91% 398.57% -44.01% 51.59% -69.19% 196.25% -41.60%
Free Cash Flow Firm Q/Q Growth		 157.36% 421.26% -102.28% 3,257.75% 127.99% -12.48% 115.05% 197.66% -214.55% 450.19%
Invested Capital Q/Q Growth		 -2.75% 0.67% -0.96% 2.71% -5.04% 1.27% -3.21% 1.58% -2.28% -4.52%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 65.26% 65.66% 65.40% 65.94% 66.47% 65.98% 66.17% 66.83% 66.52% 66.17%
EBITDA Margin		 25.73% 22.19% 22.89% 25.25% 26.81% 23.54% 27.26% 26.09% 28.26% 20.92%
Operating Margin		 3.54% 4.49% 4.19% 5.79% 6.91% 6.03% 7.82% 6.16% 8.89% 6.32%
EBIT Margin		 7.32% 4.12% 4.56% 6.50% 7.75% 4.34% 8.99% 7.41% 10.23% 2.22%
Profit (Net Income) Margin		 5.45% 3.57% 3.80% 5.97% 5.50% 6.50% 7.18% 5.82% 7.83% 6.58%
Tax Burden Percent		 74.44% 74.92% 83.51% 91.84% 70.92% 84.73% 79.89% 78.64% 76.55% 89.16%
Interest Burden Percent		 100.00% 115.72% 100.00% 100.00% 100.00% 176.97% 100.00% 100.00% 100.00% 332.79%
Effective Tax Rate		 25.56% 25.08% 16.49% 8.16% 29.08% 15.27% 20.11% 21.36% 23.45% 10.84%
Return on Invested Capital (ROIC)		 2.53% 3.23% 3.48% 5.19% 5.03% 5.23% 6.43% 4.93% 7.25% 6.18%
ROIC Less NNEP Spread (ROIC-NNEP)		 -0.49% 2.99% 3.12% 4.33% 4.40% 3.71% 5.39% 3.84% 6.29% 5.34%
Return on Net Nonoperating Assets (RNNOA)		 0.09% -0.52% -0.55% -0.68% -0.87% -0.71% -1.04% -0.72% -1.41% -1.28%
Return on Equity (ROE)		 2.62% 2.71% 2.94% 4.50% 4.16% 4.52% 5.39% 4.21% 5.83% 4.89%
Cash Return on Invested Capital (CROIC)		 2.37% 5.06% 2.34% 3.98% 7.19% 7.04% 4.27% 5.18% 3.07% 9.27%
Operating Return on Assets (OROA)		 3.94% 2.23% 2.50% 3.67% 4.39% 2.43% 5.01% 4.26% 5.89% 1.28%
Return on Assets (ROA)		 2.93% 1.94% 2.08% 3.37% 3.11% 3.64% 4.01% 3.35% 4.51% 3.80%
Return on Common Equity (ROCE)		 2.62% 2.71% 2.94% 4.50% 4.16% 4.52% 5.39% 4.21% 5.83% 4.89%
Return on Equity Simple (ROE_SIMPLE)		 2.80% 0.00% 3.52% 3.78% 3.82% 0.00% 5.17% 5.11% 5.54% 0.00%
Net Operating Profit after Tax (NOPAT)		 1.77 2.31 2.41 3.68 3.45 3.61 4.55 3.47 4.97 4.18
NOPAT Margin		 2.64% 3.37% 3.50% 5.32% 4.90% 5.11% 6.25% 4.85% 6.80% 5.63%
Net Nonoperating Expense Percent (NNEP)		 3.02% 0.24% 0.36% 0.86% 0.63% 1.52% 1.04% 1.09% 0.96% 0.84%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.69% - - - 1.06% - - - 1.16%
Cost of Revenue to Revenue		 34.74% 34.34% 34.60% 34.06% 33.53% 34.02% 33.83% 33.17% 33.48% 33.83%
SG&A Expenses to Revenue		 13.52% 13.14% 12.86% 13.10% 13.21% 11.96% 11.42% 13.35% 11.57% 11.86%
R&D to Revenue		 17.06% 17.23% 16.94% 15.94% 15.50% 16.90% 16.54% 16.88% 16.55% 17.08%
Operating Expenses to Revenue		 61.72% 61.16% 61.21% 60.15% 59.55% 59.95% 58.35% 60.66% 57.63% 59.86%
Earnings before Interest and Taxes (EBIT)		 4.93 2.83 3.14 4.50 5.45 3.06 6.54 5.30 7.48 1.65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 17 15 16 17 19 17 20 19 21 16
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.95 2.26 2.45 2.20 1.93 2.39 2.34 2.43 2.47 2.69
Price to Tangible Book Value (P/TBV)		 25.96 32.76 30.07 21.45 16.52 20.03 16.71 15.26 13.72 13.97
Price to Revenue (P/Rev)		 2.46 2.82 3.04 2.74 2.38 2.92 2.85 2.97 3.05 3.32
Price to Earnings (P/E)		 69.73 62.31 69.61 58.25 50.46 53.60 45.23 47.46 44.49 48.34
Dividend Yield		 0.00% 0.00% 0.00% 0.20% 0.35% 0.37% 0.48% 0.47% 0.46% 0.43%
Earnings Yield		 1.43% 1.61% 1.44% 1.72% 1.98% 1.87% 2.21% 2.11% 2.25% 2.07%
Enterprise Value to Invested Capital (EV/IC)		 2.15 2.52 2.78 2.46 2.19 2.76 2.67 2.77 2.90 3.32
Enterprise Value to Revenue (EV/Rev)		 2.24 2.60 2.81 2.52 2.11 2.67 2.61 2.73 2.76 2.98
Enterprise Value to EBITDA (EV/EBITDA)		 9.88 10.91 11.81 10.41 8.61 10.83 9.82 10.21 10.19 11.65
Enterprise Value to EBIT (EV/EBIT)		 49.83 45.90 50.77 43.54 35.66 46.07 33.66 34.30 32.18 41.49
Enterprise Value to NOPAT (EV/NOPAT)		 84.39 71.95 85.10 68.63 49.22 56.53 48.20 51.57 47.91 50.67
Enterprise Value to Operating Cash Flow (EV/OCF)		 12.01 13.58 14.88 14.16 10.02 11.63 11.46 11.83 13.20 15.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 90.74 49.46 119.44 61.62 30.07 38.79 62.87 53.56 95.77 35.29
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.05 0.05 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.05 0.05 0.00
Financial Leverage		 -0.19 -0.17 -0.17 -0.16 -0.20 -0.19 -0.19 -0.19 -0.22 -0.24
Leverage Ratio		 1.45 1.46 1.50 1.46 1.46 1.48 1.49 1.44 1.43 1.44
Compound Leverage Factor		 1.45 1.69 1.50 1.46 1.46 2.62 1.49 1.44 1.43 4.80
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.35% 5.10% 4.81% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.35% 5.10% 4.81% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 94.65% 94.90% 95.19% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.26 0.25 0.23 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 -0.91 -0.89 -1.04 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.26 0.25 0.23 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 1.27 1.24 1.08 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 -4.46 -4.52 -4.87 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 1.27 1.24 1.08 0.00
Altman Z-Score		 3.37 3.54 3.75 3.79 3.41 3.94 3.81 4.33 4.57 4.80
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.99 0.98 1.03 1.08 1.11 1.10 1.17 1.24 1.32 1.32
Quick Ratio		 0.80 0.82 0.88 0.89 0.93 0.93 1.01 1.07 1.14 1.15
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1.29 6.70 -0.15 4.82 11 9.63 0.98 2.91 -3.33 12
Operating Cash Flow to CapEx		 253.17% 132.05% 243.23% 79.22% 367.37% 209.27% 269.78% 96.21% 279.44% 163.23%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.54 0.54 0.55 0.56 0.57 0.56 0.56 0.57 0.58 0.58
Accounts Receivable Turnover		 8.28 6.87 6.14 7.23 8.21 6.88 6.19 7.40 8.66 7.91
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 15.45 15.96 17.03 17.71 18.98 19.59 20.78 21.66 23.39 24.56
Accounts Payable Turnover		 4.09 14.69 4.91 4.66 7.35 12.88 7.53 6.87 24.32 13.90
Days Sales Outstanding (DSO)		 44.07 53.10 59.44 50.48 44.45 53.07 58.93 49.31 42.13 46.16
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 89.32 24.86 74.36 78.35 49.64 28.33 48.46 53.16 15.01 26.26
Cash Conversion Cycle (CCC)		 -45.25 28.24 -14.91 -27.87 -5.18 24.74 10.47 -3.85 27.12 19.90
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 274 276 273 280 266 270 277 281 275 262
Invested Capital Turnover		 0.96 0.96 1.00 0.98 1.03 1.02 1.03 1.02 1.07 1.10
Increase / (Decrease) in Invested Capital		 0.49 -4.39 2.57 -1.14 -7.55 -6.02 3.57 0.56 8.30 -7.48
Enterprise Value (EV)		 589 695 760 689 584 744 738 779 796 870
Market Capitalization		 645 753 823 750 660 815 806 847 877 967
Book Value per Share		 $10.80 $10.93 $10.99 $11.10 $11.15 $11.25 $11.38 $11.49 $11.69 $11.82
Tangible Book Value per Share		 $0.81 $0.75 $0.90 $1.14 $1.30 $1.34 $1.59 $1.83 $2.10 $2.28
Total Capital		 330 334 336 341 342 341 364 368 373 359
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 19 19 18 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 19 19 18 0.00
Net Debt		 -56 -58 -63 -60 -76 -71 -68 -68 -81 -97
Capital Expenditures (CapEx)		 5.96 6.14 8.45 6.25 6.72 6.60 7.76 6.71 6.84 6.84
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -53 -57 -55 -47 -60 -59 -62 -56 -60 -60
Debt-free Net Working Capital (DFNWC)		 -1.04 -2.84 4.10 8.86 12 12 21 27 35 37
Net Working Capital (NWC)		 -1.04 -2.84 4.10 8.86 12 12 21 27 35 37
Net Nonoperating Expense (NNE)		 -1.89 -0.14 -0.21 -0.45 -0.42 -0.98 -0.68 -0.70 -0.75 -0.71
Net Nonoperating Obligations (NNO)		 -56 -58 -63 -60 -76 -71 -68 -68 -81 -97
Total Depreciation and Amortization (D&A)		 12 12 13 13 13 14 13 13 13 14
Debt-free, Cash-free Net Working Capital to Revenue		 -20.14% -21.27% -20.17% -17.19% -21.48% -21.24% -22.04% -19.55% -20.77% -20.50%
Debt-free Net Working Capital to Revenue		 -0.40% -1.06% 1.52% 3.23% 4.44% 4.25% 7.54% 9.55% 12.18% 12.83%
Net Working Capital to Revenue		 -0.40% -1.06% 1.52% 3.23% 4.44% 4.25% 7.54% 9.55% 12.18% 12.83%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.12 $0.08 $0.09 $0.13 $0.13 $0.15 $0.17 $0.14 $0.19 $0.16
Adjusted Weighted Average Basic Shares Outstanding		 30.57M 30.65M 30.59M 30.68M 30.68M 30.57M 30.31M 30.40M 30.41M 30.39M
Adjusted Diluted Earnings per Share		 $0.12 $0.08 $0.09 $0.13 $0.13 $0.15 $0.17 $0.14 $0.19 $0.16
Adjusted Weighted Average Diluted Shares Outstanding		 30.66M 30.72M 30.66M 30.78M 30.77M 30.67M 30.42M 30.53M 30.59M 30.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 30.57M 30.58M 30.68M 30.69M 30.29M 30.30M 30.40M 30.41M 30.41M 30.43M
Normalized Net Operating Profit after Tax (NOPAT)		 1.77 2.31 2.41 3.68 3.45 3.61 4.55 3.47 4.97 4.18
Normalized NOPAT Margin		 2.64% 3.37% 3.50% 5.32% 4.90% 5.11% 6.25% 4.85% 6.80% 5.63%
Pre Tax Income Margin		 7.32% 4.77% 4.56% 6.50% 7.75% 7.68% 8.99% 7.41% 10.23% 7.38%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 11.92% 17.60% 20.10% 21.93% 18.06% 16.78% 17.01%
Augmented Payout Ratio		 304.11% 191.36% 0.00% 11.92% 30.21% 78.79% 21.93% 18.06% 53.72% 17.01%

Frequently Asked Questions About HealthStream's Financials

When does HealthStream's fiscal year end?

According to the most recent income statement we have on file, HealthStream's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has HealthStream's net income changed over the last 10 years?

HealthStream's net income appears to be on an upward trend, with a most recent value of $20.01 million in 2024, rising from $10.39 million in 2014. The previous period was $15.21 million in 2023. View HealthStream's forecast to see where analysts expect HealthStream to go next.

What is HealthStream's operating income?
HealthStream's total operating income in 2024 was $21.29 million, based on the following breakdown:
  • Total Gross Profit: $193.71 million
  • Total Operating Expenses: $172.42 million
How has HealthStream revenue changed over the last 10 years?

Over the last 10 years, HealthStream's total revenue changed from $170.69 million in 2014 to $291.65 million in 2024, a change of 70.9%.

How much debt does HealthStream have?

HealthStream's total liabilities were at $151.41 million at the end of 2024, a 4.9% decrease from 2023, and a 69.4% increase since 2014.

How much cash does HealthStream have?

In the past 9 years, HealthStream's cash and equivalents has ranged from $36.57 million in 2020 to $134.32 million in 2018, and is currently $59.47 million as of their latest financial filing in 2024.

How has HealthStream's book value per share changed over the last 10 years?

Over the last 10 years, HealthStream's book value per share changed from 6.07 in 2014 to 11.82 in 2024, a change of 94.5%.


Related Companies

This page (NASDAQ:HSTM) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...
Colonial Metals | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...
Crypto 101 Media | Sponsored
Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...
Timothy Sykes | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Man who predicted $100K Bitcoin sees a huge run coming for another coin …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...
Weiss Ratings | Sponsored
Musk's warning signal: Prepare before the cascade begins
When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...
InvestorPlace | Sponsored